Natalie Gassen

Natalie Gassen has extensive work experience in various finance and leadership roles. Natalie is currently the Chief Financial Officer and Chief Operating Officer at Helios Clinical Research since October 2022. Prior to that, they served as the Chief Financial Officer at Allucent from December 2021 to August 2022. Before Allucent, they held the position of Chief Financial Officer at Pharm-Olam, LLC from December 2015 to June 2022. Natalie also briefly worked as the Director of Global Finance and Accounting at Pharm-Olam, LLC from July 2015 to November 2015. From June 2011 to July 2015, they worked as the Chief Financial Officer at ApoCell, Inc., where they led various administrative functions and played a key role in capital raise initiatives. Earlier in their career, they were the Chief Financial Officer at Triad Resources from July 2008 to October 2011 and served as the Controller at Triad Resources from April 2004 to July 2008. Natalie started their career as an Auditor at Deloitte and Touche LLP from September 1998 to February 2000. Prior to that, they worked as the Manager of Project Accounting at BMC Software Inc from February 2000 to April 2004.

Natalie Gassen has a Bachelor of Business Administration (BBA) degree with a focus in Accounting. Natalie attended Lamar University, although the specific start and end years of their education are unknown.